Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 40% ± 12% | |
epithelial cell of proximal tubule | 4 studies | 27% ± 4% | |
epithelial cell | 4 studies | 29% ± 13% | |
hepatocyte | 4 studies | 33% ± 10% | |
conventional dendritic cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1956.20 | 328 / 328 | 100% | 33.30 | 178 / 178 |
liver | 100% | 18898.91 | 226 / 226 | 100% | 239.07 | 404 / 406 |
thymus | 100% | 2202.28 | 653 / 653 | 99% | 43.81 | 601 / 605 |
bladder | 100% | 1135.19 | 21 / 21 | 98% | 57.58 | 496 / 504 |
breast | 100% | 2261.86 | 458 / 459 | 98% | 53.53 | 1101 / 1118 |
stomach | 98% | 1258.46 | 353 / 359 | 99% | 51.56 | 282 / 286 |
prostate | 100% | 1003.49 | 244 / 245 | 97% | 23.60 | 488 / 502 |
lung | 99% | 1930.10 | 570 / 578 | 97% | 34.00 | 1125 / 1155 |
skin | 100% | 2069.39 | 1805 / 1809 | 96% | 32.10 | 454 / 472 |
kidney | 100% | 6255.08 | 89 / 89 | 95% | 35.33 | 858 / 901 |
esophagus | 97% | 1274.20 | 1405 / 1445 | 95% | 26.03 | 173 / 183 |
intestine | 89% | 4764.57 | 856 / 966 | 99% | 73.16 | 520 / 527 |
uterus | 86% | 646.74 | 147 / 170 | 97% | 35.88 | 443 / 459 |
adrenal gland | 97% | 1083.10 | 249 / 258 | 83% | 26.95 | 191 / 230 |
ovary | 27% | 165.68 | 48 / 180 | 88% | 19.06 | 380 / 430 |
brain | 54% | 310.40 | 1428 / 2642 | 56% | 9.00 | 396 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.96 | 29 / 29 |
spleen | 100% | 2335.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.46 | 1 / 1 |
adipose | 100% | 2655.48 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1220.50 | 1319 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 41.22 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 95% | 22.38 | 76 / 80 |
peripheral blood | 91% | 1822.67 | 842 / 929 | 0% | 0 | 0 / 0 |
heart | 35% | 209.53 | 303 / 861 | 0% | 0 | 0 / 0 |
muscle | 7% | 36.12 | 53 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0046327 | Biological process | glycerol biosynthetic process from pyruvate |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0006107 | Biological process | oxaloacetate metabolic process |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0042594 | Biological process | response to starvation |
GO_0006116 | Biological process | NADH oxidation |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0006094 | Biological process | gluconeogenesis |
GO_0070365 | Biological process | hepatocyte differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0019543 | Biological process | propionate catabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004611 | Molecular function | phosphoenolpyruvate carboxykinase activity |
GO_0004613 | Molecular function | phosphoenolpyruvate carboxykinase (GTP) activity |
GO_0030145 | Molecular function | manganese ion binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PCK2 |
Protein name | Phosphoenolpyruvate carboxykinase 2, mitochondrial Phosphoenolpyruvate carboxykinase 2 isoform 3 phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32) (Phosphoenolpyruvate carboxykinase 2, mitochondrial) (mtPCK2) |
Synonyms | hCG_40169 PEPCK2 |
Description | FUNCTION: Mitochondrial phosphoenolpyruvate carboxykinase that catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle . Can play an active role in glyceroneogenesis and gluconeogenesis . . |
Accessions | ENST00000644679.1 [Q16822-3] H0YMU6 H0YKC4 H0YMA5 ENST00000216780.9 [Q16822-1] H0YML5 ENST00000558096.5 ENST00000645217.2 [Q16822-1] Q16822 ENST00000559584.5 ENST00000545054.6 [Q16822-3] ENST00000396973.8 [Q16822-2] A0A0S2Z451 Q6IB91 ENST00000560736.5 H0YNG4 H0YMY3 A0A0S2Z4C0 ENST00000559171.1 ENST00000560106.5 ENST00000645536.1 [Q16822-3] ENST00000559837.5 A0A384MTT2 A0A0S2Z430 H0YNH9 ENST00000561286.5 [Q16822-3] ENST00000559250.5 ENST00000559503.1 H0YM31 ENST00000645709.1 [Q16822-2] |